We specifically examined the role of leukocyte immunoglobulin-like receptor 4a (LILRB4a or LILRB4), which is known to suppress immunity in acute myeloid leukemia (AML) and solid tumors [18]. The gene discussed is LILRB4; the disease is acute myeloid leukemia.